Robert Purcell

Q: What Schools Are Affiliated With Robert Purcell

Robert Purcell is affiliated with the following schools: University of New South Wales, Iowa State University, Stanford University, Georgetown University, Cornell University, Johns Hopkins University, University of Oklahoma, University of Cagliari, University of Turku, Baylor University, Uniformed Services University of the Health Sciences, Duke University

Robert Purcell 's AcademicInfluence.com Rankings

Robert Purcell

Biology

#2465

World Rank

#3903

Historical Rank

#1098

USA Rank

Virology

#35

World Rank

#37

Historical Rank

#15

USA Rank

Microbiology

#58

World Rank

#76

Historical Rank

#28

USA Rank

biology Degrees

Download Badge

Biology

Why Is Robert Purcell Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robert Harry Purcell is an American virologist and former co-chief of the Laboratory of Infectious Diseases at the U.S. National Institute of Allergy and Infectious Disease. He is known for his work on hepatitis viruses, and was involved in identifying hepatitis A virus, hepatitis D virus, and hepatitis E virus, developing an animal model for hepatitis B, and developing the hepatitis A vaccine.

(See a Problem?)

Robert Purcell 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis (1989) (2297)
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. (1989) (1655)
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. (1990) (1536)
Viral clearance without destruction of infected cells during acute HBV infection. (1999) (1233)
Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus (1990) (1227)
Comparative Genomics of Listeria Species (2001) (1121)
A novel virus in swine is closely related to the human hepatitis E virus. (1997) (1111)
National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C (1997) (1042)
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. (2000) (943)
CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection (2003) (889)
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. (1995) (886)
Genomic analysis of the host response to hepatitis C virus infection (2002) (846)
Hepatitis A: Detection by Immune Electron Microscopy of a Viruslike Antigen Associated with Acute Illness (1973) (806)
An African primate lentivirus (SIVsmclosely related to HIV-2 (1989) (780)
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease (2002) (693)
DNA Polymerase Associated with Human Hepatitis B Antigen (1973) (692)
Hepatitis E: an emerging awareness of an old disease. (2008) (685)
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. (1990) (636)
Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo1 (2000) (627)
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. (1996) (626)
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. (1991) (595)
Hepatitis E virus (2003) (580)
Genetic and Experimental Evidence for Cross-Species Infection by Swine Hepatitis E Virus (1998) (574)
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. (1991) (572)
Genomic analysis of the host response to hepatitis B virus infection. (2004) (557)
Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. (1997) (531)
Prevalence of Antibodies to Hepatitis E Virus in Veterinarians Working with Swine and in Normal Blood Donors in the United States and Other Countries (2002) (521)
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. (1994) (515)
Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. (1980) (466)
Structural and functional characterization of human immunodeficiency virus tat protein (1989) (438)
EPIDEMIC AND ENDEMIC HEPATITIS IN INDIA: EVIDENCE FOR A NON-A, NON-B HEPATITIS VIRUS ÆTIOLOGY (1980) (437)
At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. (1993) (435)
Sequence analysis of the 5' noncoding region of hepatitis C virus. (1992) (432)
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses (1994) (430)
Transfusion‐associated hepatitis not due to viral hepatitis type A or B † (1975) (390)
Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses (1987) (382)
delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. (1980) (381)
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes (1993) (379)
TRANSMISSIBLE AGENT IN NON-A, NON-B HEPATITIS (1978) (374)
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks (1993) (371)
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. (1976) (367)
A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species (2001) (367)
Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention (2007) (360)
In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes (2003) (357)
CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITIS (1975) (347)
Hepatitis C in hospital employees with needlestick injuries. (1991) (344)
Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. (1992) (341)
Sequence analysis of the core gene of 14 hepatitis C virus genotypes. (1994) (335)
Comparative Pathogenesis of Infection of Pigs with Hepatitis E Viruses Recovered from a Pig and a Human (2001) (330)
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. (1972) (320)
A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production (1966) (318)
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. (1986) (317)
Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. (1995) (317)
SEROLOGICAL RESPONSE TO THE HEPATITIS DELTA VIRUS IN HEPATITIS D (1987) (304)
Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. (2011) (300)
Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. (1989) (294)
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro (1983) (290)
The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences (2003) (288)
Characterization of a prototype strain of hepatitis E virus. (1992) (286)
Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children (1994) (286)
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. (2005) (282)
The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection (2009) (279)
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. (1979) (277)
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. (1978) (275)
Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus–host recombinant (2011) (271)
Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. (1987) (270)
Protective effect of antibody to parainfluenza type 1 virus. (1966) (269)
Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. (1992) (265)
Hepatocarcinogenicity of the woodchuck hepatitis virus. (1987) (261)
Live recombinant vaccinia virus protects chimpanzees against hepatitis B (1984) (254)
Hepatitis B and hepatitis C in emergency department patients. (1992) (254)
In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. (1999) (251)
Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. (2004) (251)
Donor transaminase and recipient hepatitis. Impact on blood transfusion services. (1981) (250)
The chronic sequelae of non-A, non-B hepatitis. (1979) (248)
Evidence for widespread infection of wild rats with hepatitis E virus in the United States. (1999) (247)
Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV (1998) (247)
Seroreactivity to hepatitis E virus in areas where the disease is not endemic (1997) (242)
Evaluation of assays for antibody to hepatitis E virus by a serum panel (1998) (235)
Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. (1989) (234)
Transmission of Hepatitis A to Patients with Hemophilia by Factor VIII Concentrates Treated with Organic Solvent and Detergent To Inactivate Viruses (1994) (232)
Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. (2004) (232)
Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. (1998) (227)
Thermal stability of hepatitis E virus. (2005) (226)
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome (2002) (225)
EPIDEMIOLOGY OF HBV-ASSOCIATED DELTA AGENT: GEOGRAPHICAL DISTRIBUTION OF ANTI-DELTA AND PREVALENCE IN POLYTRANSFUSED HBsAg CARRIERS (1980) (225)
DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. (1996) (217)
Clinical significance of hepatitis C virus genotypes and quasispecies. (2000) (216)
ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. (1993) (216)
Multiple Hepatitis Viruses in Multiple Attacks of Acute Viral Hepatitis (1977) (214)
Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees (2004) (213)
Successful passive and active immunization of cynomolgus monkeys against hepatitis E. (1994) (211)
A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. (1976) (209)
Ureaplasma urealyticum gen. nov., sp. nov.: Proposed Nomenclature for the Human T (T-Strain) Mycoplasmas (1974) (207)
A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. (1996) (207)
Prevalence of antibodies to the hepatitis E virus in pigs from countries where hepatitis E is common or is rare in the human population (1999) (206)
Chimpanzees as an animal model for human norovirus infection and vaccine development (2010) (200)
Non-A, non-B hepatitis. (1976) (196)
Non-A, non-B hepatitis in chimpanzees and marmosets. (1981) (194)
Color Test for the Measurement of Antibody to T-Strain Mycoplasmas (1966) (194)
Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. (1994) (193)
Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. (2008) (193)
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis (1990) (189)
Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. (1994) (189)
Route and Method of Delivery of DNA Vaccine Influence Immune Responses in Mice and Non-Human Primates (1999) (187)
Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. (1999) (185)
Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. (1985) (184)
Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus (2008) (181)
Hepatitis C virus: Detection of intracellular virus particles by electron microscop (1996) (177)
Determining the size of non-A, non-B hepatitis virus by filtration. (1987) (176)
Hepatitis C virus-associated fulminant hepatic failure. (1996) (175)
High Prevalence of Hepatitis C Virus (HCV) RNA in Dialysis Patients: Failure of Commercially Available Antibody Tests to Identify a Significant Number of Patients with HCV Infection (1993) (173)
A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA (2007) (172)
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. (2000) (171)
INCIDENCE AND SIGNIFICANCE OF ANTIBODIES TO DELTA ANTIGEN IN HEPATITIS B VIRUS INFECTION (1979) (170)
In Vitro Replication of Hepatitis E Virus (HEV) Genomes and of an HEV Replicon Expressing Green Fluorescent Protein (2004) (170)
Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. (1993) (169)
Early events in hepatitis C virus infection of chimpanzees. (1990) (169)
Molecular cloning of feline immunodeficiency virus. (1989) (168)
Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. (1987) (167)
High prevalence of hepatitis E antibodies in pregnant Egyptian women. (2006) (166)
Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. (2004) (163)
Distribution of antibody to hepatitis a antigen in urban adult populations. (1976) (160)
Recombinant hepatitis E virus genomes infectious for primates: Importance of capping and discovery of a cis-reactive element (2001) (159)
Identification by Phage Display and Characterization of Two Neutralizing Chimpanzee Monoclonal Antibodies to the Hepatitis E Virus Capsid Protein (2000) (158)
Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus (2007) (158)
A complement-fixation test for measuring Australia antigen and antibody. (1969) (156)
NON-A, NON-B POST-TRANSFUSION HEPATITIS (1977) (156)
Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV (2000) (155)
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. (1977) (154)
Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. (1992) (151)
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees (2012) (151)
Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. (1971) (151)
Woodchuck hepatitis and hepatocellular carcinoma: Correlation of histologic with virologic observations (1981) (151)
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. (1984) (150)
Experimental infection of chimpanzees with hepatitis A virus. (1975) (150)
Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture (1987) (149)
Release of Genotype 1 Hepatitis E Virus from Cultured Hepatoma and Polarized Intestinal Cells Depends on Open Reading Frame 3 Protein and Requires an Intact PXXP Motif (2010) (149)
Hepatitis viruses: changing patterns of human disease. (1994) (149)
Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. (1975) (148)
Apolipoprotein C1 Association with Hepatitis C Virus (2008) (147)
Quasispecies in viral persistence and pathogenesis of hepatitis C virus. (1999) (146)
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. (1973) (146)
The discovery of the hepatitis viruses. (1993) (146)
Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. (1987) (146)
Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. (1997) (145)
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform (1983) (144)
Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage (1981) (144)
A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species. (1966) (144)
Comparative Evolution of GII.3 and GII.4 Norovirus over a 31-Year Period (2011) (142)
Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. (1998) (142)
Dynamics of hepatitis B virus clearance in chimpanzees. (2005) (142)
Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. (2003) (142)
Hepatitis E Virus in Rats, Los Angeles, California, USA (2011) (140)
Hepatitis B virus infection in chimpanzees: titration of subtypes. (1975) (139)
Etiology of sporadic hepatitis B surface antigen-negative hepatitis. (1977) (139)
Association of EB-virus infection with the post-perfusion syndrome. (1969) (138)
The Open Reading Frame 3 Gene of Hepatitis E Virus Contains a cis-Reactive Element and Encodes a Protein Required for Infection of Macaques (2005) (138)
Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain (2008) (137)
Transmission of non-A, non-B hepatitis. (1977) (137)
Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys (1994) (136)
Evidence that the Genomic RNA of Hepatitis E Virus Is Capped (1999) (136)
AETIOLOGICAL ASSOCIATION OF A VIRUS-LIKE PARTICLE WITH ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS (1988) (135)
The hepatitis C virus: Overview (1997) (135)
The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host (1992) (134)
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen (1977) (130)
In vivo evaluation of the cross‐genotype neutralizing activity of polyclonal antibodies against hepatitis C virus (2011) (128)
Hepatitis A virus infection: new insights from seroepidemiologic studies. (1978) (127)
Transfusion-associated hepatitis not due to viral hepatitis type A or B. 1975. (1975) (127)
Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies (2010) (126)
Prevalence of antibodies to hepatitis E in two rural Egyptian communities. (2000) (126)
Animal models of hepatitis A and E. (2001) (126)
Molecular cloning and characterization of hepatitis A virus cDNA. (1983) (123)
Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis (1986) (122)
Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations. (1970) (121)
Delta hepatitis agent: structural and antigenic properties of the delta-associated particle (1984) (120)
Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees (1997) (118)
Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. (2006) (117)
The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. (1993) (116)
Hepatitis C virus: detection of intracellular virus particles by electron microscopy. (1996) (116)
Viral hepatitis, type B (MS-2 strain). Detection of antibody after primary infection. (1971) (114)
Hepatitis E Virus (HEV) Capsid Antigens Derived from Viruses of Human and Swine Origin Are Equally Efficient for Detecting Anti-HEV by Enzyme Immunoassay (2002) (114)
ORF3 Protein of Hepatitis E Virus Is Not Required for Replication, Virion Assembly, or Infection of Hepatoma Cells In Vitro (2006) (114)
Identification of hepatitis B virus indigenous to chimpanzees. (2000) (112)
Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system (2012) (112)
Characterization of a strain of infectious hepatitis E virus isolated from sewage in an area where hepatitis E is not endemic. (1998) (112)
Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection (2000) (110)
Enzyme-Linked Immunosorbent Assay for Detection of Hepatitis A Antigen in Stool and Antibody to Hepatitis A Antigen in Sera: Comparison with Solid-Phase Radioimmunoassay, Immune Electron Microscopy, and Immune Adherence Hemagglutination Assay (1978) (109)
Enterically transmitted non-A, non-B hepatitis : epidemiology and clinical characteristics. (1988) (109)
Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination (1976) (109)
Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993). (1999) (107)
Biophysical Properties of Australia Antigen (1969) (107)
Radioimmunoassay for the detection of the core of the Dane particle and antibody to it. (1974) (106)
B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus–associated acute liver failure (2010) (105)
Compact organization of the hepatitis B virus genome (1989) (105)
Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. (1997) (105)
Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees. (1983) (104)
Mutations within Potential Glycosylation Sites in the Capsid Protein of Hepatitis E Virus Prevent the Formation of Infectious Virus Particles (2007) (104)
Histologic Studies of Severe Delta Agent Infection in Venezuelan Indians (2007) (102)
Type D hepatitis: The clinical significance of hepatitis D virus RNA in serum as detected by a hybridization‐based assay (1986) (102)
Australia Antigen: Large-Scale Purification from Human Serum and Biochemical Studies of Its Proteins (1971) (101)
Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus (1999) (100)
Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus. (2011) (100)
FÆCAL SHEDDING OF HEPATITIS-A ANTIGEN (1975) (100)
Running like water--the omnipresence of hepatitis E. (2004) (100)
Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. (2006) (96)
Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. (1989) (96)
A DOT HYBRIDISATION ASSAY FOR DETECTION OF ROTAVIRUS (1983) (94)
Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. (1995) (93)
Localization of hepatitis A antigen in marmoset organs during acute infection with hepatitis A virus. (1978) (93)
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. (2006) (93)
Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain (2008) (92)
Demonstration of subpopulations of Dane particles (1976) (91)
Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. (1997) (91)
An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. (2004) (89)
Detection of Anthrax Toxin by an Ultrasensitive Immunoassay Using Europium Nanoparticles (2009) (89)
The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia. (1992) (89)
Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. (1993) (89)
Pathogenesis of Hepatitis E Virus and Hepatitis C Virus in Chimpanzees: Similarities and Differences (2010) (89)
MODIFICATION OF CHRONIC HEPATITIS-B VIRUS INFECTION IN CHIMPANZEES BY ADMINISTRATION OF AN INTERFERON INDUCER (1976) (89)
CD 8 T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection † (2002) (88)
Titration of the infectivity of hepatitis D virus in chimpanzees. (1987) (88)
Detection of hepatitis B virus DNA in serum by polymerase chain reaction (1990) (87)
Epitope Determinants of a Chimpanzee Fab Antibody That Efficiently Cross-Neutralizes Dengue Type 1 and Type 2 Viruses Map to Inside and in Close Proximity to Fusion Loop of the Dengue Type 2 Virus Envelope Glycoprotein (2004) (86)
Human class I supertypes and CTL repertoires extend to chimpanzees. (1998) (86)
A microtiter solid phase radioimmunoassay for detection of the human reovirus-like agent in stools. (1977) (85)
The half‐life of hepatitis B virions (2006) (85)
Monoclonal Antibody Therapies against Anthrax (2011) (85)
EXUDATIVE PHARYNGITIS FOLLOWING EXPERIMENTAL MYCOPLASMA HOMINIS: TYPE 1 INFECTION. (1965) (84)
Comparison of tests for antibody to hepatitis E virus (1998) (84)
Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains (2012) (84)
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. (1976) (84)
Recombinant vaccines for hepatitis E. (2001) (83)
Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs (1986) (83)
Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues (1989) (83)
WATERBORNE NON-A, NON-B HEPATITIS (1988) (82)
Association of hepatitis E virus with an outbreak of hepatitis in Pakistan: Serologic responses and pattern of virus excretion (1992) (82)
Microtiter solid-phase radioimmunoassay for hepatitis B antigen. (1973) (82)
Epitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized Antibody (2007) (82)
Host range studies of GB virus‐B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees † (2001) (82)
Spatial Configuration of Hepatitis E Virus Antigenic Domain (2010) (81)
Etiology, pathology, and treatment of hepatocellular carcinoma in North America (1991) (81)
Detection of hepatitis A antigen by immunofluorescence (1977) (81)
Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations. (1972) (80)
Hepatitis type A, B, and non-A non-B in fulminant hepatitis. (1980) (80)
African strains of hepatitis E virus that are distinct from Asian strains (1997) (77)
Long-Term Efficacy Of Active Postexposure Immunization Of Infants For Prevention Of Hepatitis B Virus Infection (1995) (77)
Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models. (2010) (77)
The emerging pattern of post-transfusion hepatitis. (1975) (76)
Viral hepatitis, type B, in experimental animals. (1975) (75)
Counterelectrophoresis for detection of hepatitis--associated antigen: methodology and comparison with gel diffusion and complement fixation. (1971) (74)
DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface. (1999) (74)
Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. (1993) (74)
Specific histologic features of Santa Marta hepatitis: A severe form of hepatitis δ‐virus infection in Northern South America (1986) (73)
Studies of prototype live hepatitis A virus vaccines in primate models. (1988) (73)
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity (2005) (73)
2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. (1993) (73)
Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo (2008) (72)
Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains. (1991) (71)
Studies of Hepatitis C Virus in Chimpanzees and Their Importance for Vaccine Development (2001) (71)
The challenge of developing a vaccine against hepatitis C virus. (2002) (71)
Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus. (1990) (70)
The δ agent: HBsAg particles with δ antigen and RNA in the serum of an HBV carrier (1981) (69)
Hidden danger: the raw facts about hepatitis E virus. (2010) (69)
Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay (1979) (69)
Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease. (1966) (69)
Mutations in both the 2B and 2C genes of hepatitis A virus are involved in adaptation to growth in cell culture (1992) (68)
The hepatitis delta virus and its infection (1987) (68)
Inactivation of human T‐cell lymphotropic virus, type III by heat, chemicals, and irradiation (1986) (68)
Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. (2001) (67)
How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure. (1997) (67)
Declining prevalence of hepatitis E antibodies among Danish blood donors (2014) (67)
SIGNIFICANCE OF ANTIBODY TO MYCOPLASMA AS MEASURED BY METABOLIC‐INHIBITION TECHNIQUES (1967) (66)
Infection of a chimpanzee with hepatitis C virus grown in cell culture. (1998) (66)
Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA (1989) (66)
Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. (2002) (66)
A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. (2005) (65)
Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation. (1972) (65)
Fecal excretion of Greek strains of hepatitis A virus in patients with hepatitis A and in experimentally infected chimpanzees. (1986) (65)
Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. (2006) (65)
Prevalence study of antibody to ratborne pathogens and other agents among patients using a free clinic in downtown Los Angeles. (2002) (65)
Efficient Neutralization of Anthrax Toxin by Chimpanzee Monoclonal Antibodies against Protective Antigen (2006) (64)
Epidemic of hepatitis E in a military unit in Abbotrabad, Pakistan. (2002) (64)
Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus. (1975) (64)
Subtyping of hepatitis-associated antigen (HB-Ag); simplified technique with counterelectrophoresis. (1972) (64)
Experimental Infection of Chimpanzees with the Virus of Hepatitis B (1972) (64)
Primate Animal Models and Titered Inocula for the Study of Human Hepatitis A, Hepatitis B, and Non‐A, Non‐B Hepatitis (1983) (64)
Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees. (1992) (64)
High prevalence of TT virus (TTV) infection in patients on maintenance hemodialysis: Frequent mixed infections with different genotypes and lack of evidence of associated liver disease (1999) (64)
Characterization of a Strain of Infectious Hepatitis E Virus Isolated from Sewage in an Area where Hepatitis E Is Not Endemic (1998) (62)
An inactivated mycoplasma pneumoniae vaccine. (1965) (62)
Type B hepatitis: a review of current prospects for a safe and effective vaccine. (1980) (62)
In Vitro and In Vivo Mutational Analysis of the 3′-Terminal Regions of Hepatitis E Virus Genomes and Replicons (2005) (62)
Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. (1983) (62)
Mutations responsible for adaptation of hepatitis A virus to efficient growth in cell culture (1991) (62)
Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus (1984) (62)
Foodborne outbreak of hepatitis A: clinical and laboratory features of acute and protracted illness (1979) (61)
Genetic relatedness among human rotaviruses (1985) (61)
Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells (1994) (61)
Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope (1998) (61)
Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection. (1988) (61)
High prevalence of hepatitis E antibodies among Danish prisoners and drug users (2002) (60)
Role of immune serum globulins in pregnant women during an epidemic of hepatitis E (1998) (60)
Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes (1996) (59)
Hepatitis A virus in the liver and intestine of marmosets after oral inoculation (1980) (59)
NON-A NON-B HEPATITIS ASSOCIATED WITH CHRONIC LIVER DISEASE IN A HÆMODIALYSIS UNIT (1979) (59)
Complete nucleotide sequence of a molecular clone of woodchuck hepatitis virus that is infectious in the natural host. (1989) (58)
Hepatitis delta virus disease. (1986) (58)
Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine. (2003) (57)
Seroepidemiological studies of transfusion-associated hepatitis. (1971) (57)
Parenterally transmitted non-A, non-B hepatitis: an epidemic reassessed. (1977) (57)
Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus. (1998) (56)
Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase. (1985) (56)
Mycoplasma hominis and abortion. (1970) (56)
Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. (2000) (56)
Hepatitis B Markers in United States Drug Addicts with Special Emphasis on the Delta Hepatitis Virus (1984) (55)
Viral hepatitis in Colombia: A study of the “hepatitis of the Sierra Nevada de Santa Marta” (1985) (55)
The pathology of viral hepatitis types A and B in chimpanzees. A comparison. (1976) (55)
The quasispecies of hepatitis C virus and the host immune response (2004) (55)
Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus (1975) (55)
The role of hepatitis E virus infection in adult Americans with acute liver failure (2016) (55)
Serological evidence for a hepatitis e virus-related agent in goats in the United States. (2013) (55)
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure (2018) (55)
Prevalence of antibody to hepatitis A and hepatitis B viruses in selected populations of the South Pacific. (1979) (55)
Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. (1993) (54)
Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. (1989) (54)
Significance of Antibody to Mycoplasma hominis Type 1 as Measured by Indirect Hemagglutination (1965) (53)
Summary of an international workshop on hepatitis B vaccines. (1979) (52)
Characterization of Chimpanzee/Human Monoclonal Antibodies to Vaccinia Virus A33 Glycoprotein and Its Variola Virus Homolog In Vitro and in a Vaccinia Virus Mouse Protection Model (2007) (52)
In Vivo Study of the HC-TN Strain of Hepatitis C Virus Recovered from a Patient with Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) Are Infectious in Chimpanzees but Not in Huh7.5 Cells (2007) (51)
Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding (2009) (51)
A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus. (1987) (51)
Failure of Australia antibody to prevent post-transfusion hepatitis. (1969) (51)
Hepatitis type A and hemodialysis: a seroepidemiologic study in 15 U.S. centers. (1977) (51)
Molecular Cloning of SIV From Sooty Mangabey Monkeys (1989) (50)
Sequence comparison of woodchuck hepatitis virus replicative forms shows conservation of the genome. (1988) (50)
MUSSEL-ASSOCIATED VIRAL HEPATITIS, TYPE A: SEROLOGICAL CONFIRMATION (1976) (50)
Development of Norwalk Virus-Specific Monoclonal Antibodies with Therapeutic Potential for the Treatment of Norwalk Virus Gastroenteritis (2013) (49)
Detection of Immunoglobulin M Antibodies to Hepatitis E Virus by Class Capture Enzyme Immunoassay (2003) (49)
Chronic hepatitis D virus (HDV) infection in hepatitis B virus carrier chimpanzees experimentally superinfected with HDV. (1988) (48)
Report of a workshop: waterborne non-A, non-B hepatitis. (1987) (48)
Natural and experimental infection of woodchucks with woodchuck hepatitis virus, as measured by new, specific assays for woodchuck surface antigen and antibody (1982) (48)
Relationship of hepatitis A antigen to viral hepatitis. (1975) (48)
cDNA clone of hepatitis A virus encoding a virulent virus: induction of viral hepatitis by direct nucleic acid transfection of marmosets (1992) (47)
Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. (2009) (47)
Foodhandler-associated outbreak of hepatitis type A. An immune electron microscopic study. (1975) (47)
Epidemiology and clinical characteristics of acute hepatitis types A, B, and non-A non-B. (1979) (47)
Novel Chimpanzee/Human Monoclonal Antibodies That Neutralize Anthrax Lethal Factor, and Evidence for Possible Synergy with Anti-Protective Antigen Antibody (2009) (46)
Contamination of commercially available fetal bovine sera with bovine viral diarrhea virus genomes: implications for the study of hepatitis C virus in cell cultures. (1996) (46)
Chimpanzee Fab Fragments and a Derived Humanized Immunoglobulin G1 Antibody That Efficiently Cross-Neutralize Dengue Type 1 and Type 2 Viruses (2004) (46)
Acute hepatitis caused by a novel strain of hepatitis E virus most closely related to United States strains. (2001) (46)
Localization of hepatitis A antigen in liver tissue by peroxidase-conjugated antibody method: light and electron microscopic studies. (1978) (45)
Partial sequence comparison of eight new Chinese strains of hepatitis E virus suggests the genome sequence is relatively stable (1993) (45)
Non-specificity of anti-HCV test for seroepidemiological analysis (1990) (45)
Mycoplasmas of the human urogenital tract and oropharynx and their possible role in disease: a review with some recent observations. (1966) (44)
Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor (2013) (44)
Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization (1987) (44)
Hepatitis E. (2012) (44)
Hepatitis C virus receptors claudin‐1 and occludin after liver transplantation and influence on early viral kinetics (2011) (43)
Cytoplasmic Tubular Structures in Liver of HBsAg Carrier Chimpanzees Infected with Delta Agent and Comparison with Cytoplasmic Structures in Non‐A, Non‐B Hepatitis (2007) (43)
Amplification of the full-length hepatitis A virus genome by long reverse transcription-PCR and transcription of infectious RNA directly from the amplicon. (1996) (43)
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen. (1972) (43)
Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis. (1990) (43)
Identification of Chimpanzee Fab Fragments by Repertoire Cloning and Production of a Full-Length Humanized Immunoglobulin G1 Antibody That Is Highly Efficient for Neutralization of Dengue Type 4 Virus (2004) (43)
Acute viral hepatitis in Saudi Arabia: seroepidemiological analysis, risk factors, clinical manifestations, and evidence for a sixth hepatitis agent. (1995) (42)
Identification of VP1/2A and 2C as Virulence Genes of Hepatitis A Virus and Demonstration of Genetic Instability of 2C (2002) (42)
Nonhuman primate-associated viral hepatitis type A. Serologic evidence of hepatitis A virus infection. (1976) (42)
Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum. (1970) (41)
Antibody to hepatitis A antigen in institutionalized mentally retarded patients. (1977) (41)
Positive reactions on Western blots do not necessarily indicate the epitopes on antigens are continuous (2007) (41)
The woodchuck animal model of hepatitis B-like virus infection and disease. (1983) (41)
Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis (2011) (41)
Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell‐culture‐derived H77/JFH1 chimeric infectious virus particles (2009) (41)
DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice. (2002) (40)
Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathology (2017) (40)
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis (2012) (39)
Buoyant Density of the Hepatitis A Virus-Like Particle in Cesium Chloride (1974) (39)
Failure to Demonstrate Circulating Interferon During Incubation Period and Acute Stage of Transfusion-Associated Hepatitis (1971) (39)
Identification of the 5′ terminal sequence of the SAR‐55 and MEX‐14 strains of hepatitis E virus and confirmation that the genome is capped (2001) (39)
Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge (2015) (39)
Quantification of hepatitis B virus genomes and infectivity in human serum samples (2006) (39)
Relative infectivity of hepatitis A virus by the oral and intravenous routes in 2 species of nonhuman primates. (2002) (38)
Double infections with hepatitis A and B viruses. (2008) (38)
Hemolysin of Mycoplasma pneumoniae (1965) (37)
Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee. (1999) (37)
Review of infectivity studies in nonhuman primates with virus-like particles associated with MS-1 hepatitis. (1975) (37)
The Size of the Hepatitis Delta Agent (1989) (37)
Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine. (1984) (36)
Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees (1988) (36)
In vitro and ex vivo inhibition of hepatitis A virus 3C proteinase by a peptidyl monofluoromethyl ketone. (1997) (36)
High prevalence of TT virus (TTV) in naive chimpanzees and in hepatitis C virus-infected humans: frequent mixed infections and identification of new TTV genotypes in chimpanzees. (2000) (35)
Mycoplasma hominis septicemia associated with abortion. (1967) (35)
Polyprotein Processing in Echovirus 22 (EV22): A First Assessment (1995) (35)
Biology and genetic heterogeneity of hepatitis C virus. (1995) (34)
Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen (1986) (34)
Limited Hepatitis B Virus Replication Space in the Chronically Hepatitis C Virus-Infected Liver (2014) (34)
High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. (1993) (34)
Evidence against a requisite role for defective virus in the establishment of persistent hepadnavirus infections. (1990) (33)
Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein. (2006) (33)
Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay. (2007) (32)
Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate. (1992) (32)
Epidemiology of the delta agent: an introduction. (1983) (32)
Radioimmunoassay for antibody to hepatitis B surface antigen shows transmission of hepatitis B virus among household contacts. (1976) (32)
Epidemiologic aspects of Santa Marta hepatitis over a 40‐year period (1986) (32)
Pathobiology of hepatitis E: lessons learned from primate models (2013) (32)
Hepatitis A virus translation is rate-limiting for virus replication in MRC-5 cells. (1999) (31)
Testing of CpG-Optimized Protein and DNA Vaccines against the Hepatitis B Virus in Chimpanzees for Immunogenicity and Protection from Challenge (2006) (31)
Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection (1989) (31)
Spontaneous resolution of severe aplastic anemia associated with viral hepatitis a in a 6‐year‐old child (1978) (31)
The significance of infections with two types of viral hepatitis demonstrated by histologic features in chimpanzees. (1990) (31)
Hepatitis B virus, hepatitis non‐A, non‐B virus and hepatitis delta virus in lyophilized antihemophilic factor: Relative sensitivity to heat (1985) (31)
Role of mycoplasmas in human respiratory disease. (1967) (31)
Expression of hepatitis B virus-specific markers in asymptomatic hepatitis B surface antigen carriers (1977) (31)
Detection and Identification by Immune Electron Microscopy of Fastidious Agents Associated with Respiratory Illness, Acute Nonbacterial Gastroenteritis, and Hepatitis A (1975) (31)
IgM antibody to hepatitis B core antigen: a marker of infectivity. (1985) (31)
A milestone for hepatitis C virus research: a virus generated in cell culture is fully viable in vivo. (2006) (30)
Experimental transmission of the delta agent to chimpanzees. (1983) (30)
Transmission of Clonal Hepatitis C Virus Genomes Reveals the Dominant but Transitory Role of CD8+ T Cells in Early Viral Evolution (2011) (30)
Using improved technology for filter paper-based blood collection to survey wild Sika deer for antibodies to hepatitis E virus. (2007) (30)
Hepatitis C virus: Historical perspective and current concept (1994) (30)
A new Chinese isolate of Hepatitis E virus: Comparison with strains recovered from different geographical regions (1994) (29)
Correlation between fluorescent antibody detection of hepatitis B core antigen in liver biopsies and the presence of e antigen in serum (1976) (29)
Purification and characterization of recombinant Rev protein of human immunodeficiency virus type 1. (1990) (29)
Hepatitis B vaccines. On the threshold. (1978) (29)
Basis of hepatitis delta virus disease? (1989) (28)
PLC/PRF/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity (1980) (28)
Differences in the prevalence of hepatitis B antigen and antibody among Panamanian Indian populations. (1973) (28)
Quantitation of antibody to hepatitis A antigen by immune electron microscopy (1976) (28)
Live attenuated vaccine for hepatitis A. (1983) (28)
Radioimmunoassay and characterization of woodchuck hepatitis virus core antigen and antibody. (1985) (28)
Immunofluorescence of hepatitis A virus antigen in chimpanzees (1978) (28)
Reappearance of hepatitis D virus (HDV) replication in chronic hepatitis B virus carrier chimpanzees rechallenged with HDV. (1989) (27)
Experimental hepatitis delta virus infection in the chimpanzee. (1987) (27)
A simian strain of hepatitis A virus, AGM-27, functions as an attenuated vaccine for chimpanzees. (1996) (27)
Serologic Evidence of Hepatitis A and B Virus Infections in Thalassemia Patients: A Retrospective Study (1978) (27)
Hepatitis C Virus : An Infectious Molecular Clone of a Second Major Genotype ( 2 a ) and Lack of Viability of Intertypic 1 a and 2 a Chimeras (1999) (27)
Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules (2006) (27)
Polyprotein processing in echovirus 22: a first assessment. (1995) (26)
Non-A, non-B hepatitis. (1976) (26)
Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays (2008) (26)
Varicella in chimpanzees (1996) (26)
Riboprobe assay for HDV RNA: A sensitive method for the detection of the HDV genome in clinical serum samples (1990) (26)
Utilization of Chimeras between Human (HM-175) and Simian (AGM-27) Strains of Hepatitis A Virus To Study the Molecular Basis of Virulence (1998) (25)
Mouse Monoclonal Antibodies to Anthrax Edema Factor Protect against Infection (2011) (25)
Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets. (1995) (25)
Animal model of human disease. Chimpanzee carriers of hepatitis B virus. Chimpanzee hepatitis B carriers. (1981) (25)
Chronic Hepatitis E with Neurologic Manifestations and Rapid Progression of Liver Fibrosis in a Liver Transplant Recipient (2013) (25)
Identification of acid-inducing agent and related mycoplasma as mycoplasma hyorhinis. (1966) (24)
Characterization of antibodies to the structural polypeptides of HGSAg: evidence for subtype-specific determinants. (1976) (24)
Attempts to transmit hepatitis B virus to chimpanzees by arthropods. (1991) (24)
Urethral infection of chimpanzees by Ureaplasma urealyticum. (1978) (24)
Hepatitis delta virus infection of the liver. (1984) (24)
Hepatitis E virus ORF2 protein over-expressed by baculovirus in hepatoma cells, efficiently encapsidates and transmits the viral RNA to naïve cells (2011) (23)
Hepatitis B Antigen (HB Ag) and Antibody (Anti‐HB Ag) in Cold Ethanol Fractions of Human Plasma (1972) (23)
Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus. (2002) (23)
Search for hepatitis B virus DNA in sera from patients with acute type B or non-A, non-B hepatitis. (1986) (23)
Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule (2010) (23)
Prevention of hepatitis B virus carriage of infants using HBV vaccine in Shanghai. Preliminary report of a randomized double-blind placebo-controlled trial. (1985) (23)
In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. (1984) (23)
The Association of Cytokines and Micronutrients with Hepatitis E Virus Infection During Pregnancy and the Postpartum Period in Rural Bangladesh. (2016) (23)
Microbiological, serological, and histopathological features of experimental Chlamydia trachomatis urethritis in chimpanzees. (1981) (23)
Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B. (1995) (22)
Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus. (1997) (22)
Cell-mediated immunity to hepatitis B surface antigen in man. (1984) (22)
Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins. (2010) (22)
Hepatitis B virus mutants and efficacy of vaccination (2000) (21)
The Ausria test: critical evaluation of sensitivity and specificity. (1973) (21)
Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure. (2013) (21)
The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier. (1981) (21)
The natural history of liver disease in former drug users (1976) (20)
Prospects for second and third generation hepatitis B vaccines (1985) (20)
Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees. (1997) (20)
Mycoplasma hominis and Postpartum Febrile Complications (1971) (20)
Experimental infection of chimpanzees with the HBsAg‐Associated delta (δdL) agent: An ultrastructural study (1984) (20)
Mutant woodchuck hepatitis virus genomes from virions resemble rearranged hepadnaviral integrants in hepatocellular carcinoma. (1993) (20)
Transfusion‐associated hepatitis before the screening of blood for hepatitis risk factors (2014) (19)
VIRUS OF AVIAN MYELOBLASTOSIS (BAI STRAIN A). XXIV. NUCLEOTIDE COMPOSITION OF THE PENTOSENUCLEIC ACID AND COMPARISON WITH STRAIN R (ERYTHROBLASTOSIS). (1963) (19)
Further studies by immunofluorescence of the monoclonal antibodies associated with experimental non‐A, non‐B hepatitis in chimpanzees and their relation to D hepatitis (1986) (19)
Use of monoclonal antibodies to determine if HBsAg of mixed subtype is one particle or two. (1986) (19)
Viral hepatitis: biological and clinical features, specific diagnosis, and prophylaxis. Second edition. (1985) (19)
Hepatitis B core antigen. Detection of antibody by radioimmunoprecipitation. (1975) (19)
Progress toward the development of a genetically engineered attenuated hepatitis A virus vaccine (1996) (19)
Hepatitis C virus: historical perspective and current concepts. (1994) (19)
Frequency and significance of delta antibody in acute and chronic hepatitis B. A United States experience. (1985) (18)
A hydrophobic heptad repeat of the core protein of woodchuck hepatitis virus is required for capsid assembly (1996) (18)
Experimental HBV and δ infections of chimpanzees: Occurrence and significance of intrahepatic immune complexes of HBcAg and δ antigen (1981) (18)
Chimpanzee livers after infection with human hepatitis viruses A and B: Ultrastructural studies. (1977) (18)
IgM levels and IgM-mediated immune responses in patients with acute hepatitis A, acute hepatitis B and chronic HB antigenaemia. (1976) (18)
Virus of avian myeloblastosis. XX. Amino acid composition. (1962) (18)
Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection (1983) (18)
Microtiter Solid-Phase Radioimmunoassay for Hepatitis B Antigen (1973) (17)
Serodiagnosis of viral hepatitis A by a solid-phase radioimmunoassay specific for IgM antibodies. (1981) (17)
Superimposed hepatitis and the effect on viral replication in chronic hepatitis B. (1986) (17)
The pathology of viral hepatitis in chimpanzees (2004) (17)
In vitro production of infectious woodchuck hepatitis virus by lipopolysaccharide-stimulated peripheral blood lymphocytes. (1989) (17)
Properties of delta-associated ribonucleic acid. (1983) (17)
Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a (2001) (17)
Proposal of Mycoplasma buccale nom. nov. and Mycoplasma faucium nom. nov. for Mycoplasma orale “Types” 2 and 3, Respectively (1974) (17)
Cytoplasmic antigen in hepatocytes of chimpanzees infected with non‐A, non‐B hepatitis virus or hepatitis delta virus: Relationship to interferon (1989) (17)
An epidemic of hepatitis A in an institution for young children. (1987) (17)
Characterization of a Newly Identified Mycoplasma (Mycoplasma orale Type 3) from the Human Oropharynx (1969) (17)
Genetic Diversity Among Simian Immunodeficiency Virus Isolates From African Green Monkeys (1989) (17)
Genetic heterogeneity of the hepatitis C virus. (1995) (17)
Electrophoretic Analysis of Cell Proteins of T-Strain Mycoplasmas Isolated from Man (1970) (16)
Partial characterization of hepatitis A viruses from three intermediate passage levels of a series resulting in adaptation to growth in cell culture and attenuation of virulence (1993) (16)
The role of acute hepatitis type A, B, and non-A non-B in the development of chronic active liver disease. (1980) (16)
ANTIBODY TO HUMAN PARVOVIRUS IN OUTBREAK OF ERYTHEMA INFECTIOSUM IN JAPAN (1985) (16)
Detection of antibodies to HAV 3C proteinase in experimentally infected chimpanzees and in naturally infected children. (2001) (16)
Hepatitis A antigen isolated from liver and stool: immunologic comparison of antisera prepared in guinea pigs. (1976) (16)
Molecular basis of virulence and growth of hepatitis A virus in cell culture. (1992) (16)
Detection of hepatitis B virus DNA in asymptomatic hepatitis B surface antigen carriers: relation to sexual transmission. (1987) (15)
Non-A non-B hepatitis associated with chronic liver disease in a haemodialysis unit. (1979) (15)
Virology of the Hepatitis A Epidemic in Italy (1994) (15)
Hepatitis Delta-Virus (2019) (15)
Failure to detect polyalbumin-binding sites on the woodchuck hepatitis virus surface antigen: implications for the pathogenesis of hepatitis B virus in humans (1986) (15)
Immunity against the GBV‐B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long‐lived (2008) (15)
Hepatitis E virus infection (2000) (14)
Seroepidemiology of hepatitis A and B in Kenya. A rural population survey in Machakos District. (1979) (14)
Etiological characterization of hepatitis B surface antigen-negative hepatitis among adult patients in Athens, Greece (1980) (14)
Apolipoprotein C 1 Association with Hepatitis C Virus (2008) (14)
High-level expression of hepatitis C virus (HCV) structural proteins by a chimeric HCV/BVDV genome propagated as a BVDV pseudotype. (2001) (14)
IMMUNE ELECTRON MICROSCOPY AND HEPATITIS A (1975) (14)
Antibody to hepatitis A antigen in children. (1977) (14)
Analysis of the X gene promoter of woodchuck hepatitis virus. (1994) (14)
A polymerase-chain reaction-based assay for serum HDV RNA. (1991) (14)
Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection. (2008) (13)
Editorial: e: a third hepatitis B antigen? (1976) (13)
Virus-like particles and GB agent hepatitis (1976) (13)
Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda (2018) (13)
Cultivation of Mycoplasmas on glass. (1971) (13)
Nuclear antigen detected in hepatoma cell lines containing integrated hepatitis B virus DNA (1983) (12)
Epidemiology of hepatitis B virus in an institution for mentally retarded persons. (1976) (12)
Comparison of serological tests for antibody to hepatitis A antigen, using coded specimens from individuals infected with the MS-1 strain of hepatitis A virus (1976) (12)
The spectrum of complement‐fixing antinuclear antibodies in patients with hepatocellular carcinoma (1985) (12)
Detection of Cytomegalovirus Antibody by Immune Adherence Hemagglutination (1976) (12)
Fulminant Hepatitis in Asymptomatic Hepatitis B Surface Antigen Carriers in Greece (1986) (12)
Genetic and Biological Characterization of Two Hepatitis B Virus Variants: A Precore Mutant Implicated in Fulminant Hepatitis and a Surface Mutant Resistant to Immunoprophylaxis (1994) (12)
Non-B hepatitis in Melbourne: a serological study of hepatitis A virus infection. (1977) (12)
Familial clustering of hepatitis B surface antigen among Panamanian Indians. (1975) (11)
A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine (1985) (11)
Occult Hepatitis B Virus Infection in Chacma Baboons, South Africa (2013) (11)
Epidemiology of acute hepatitis in the Stann Creek District of Belize, Central America. (2001) (11)
Mycoplasma lipophilum sp. nov. (1974) (11)
Effect of amantadine hydrochloride on parainfluenza type 1 virus infections in adult volunteers. (1967) (11)
Molecular markers of whv and hdv in single cells (1987) (11)
An Epidemiologic Investigation of a Case of Acute Hepatitis E (2015) (11)
Passive hemagglutination assay for antibody to subtypes of hepatitis B antigen. (1974) (10)
Clinical significance of HDV RNA in HDV disease. (1987) (10)
Non-A, non-B hepatitis after experimental transmission of malaria by inoculation of blood. (1981) (10)
Evaluation of commercially available and in-house reverse transcription-PCR assays for detection of hepatitis G virus or GB virus C (1997) (10)
Structural basis of anthrax edema factor neutralization by a neutralizing antibody. (2012) (10)
Experimental hepatitis delta virus infection in the animal model. (1991) (10)
Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E 1 Glycoprotein of Hepatitis C Virus (2007) (10)
Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice (2011) (9)
IMMUNOLOGIC DYSREGULATION AND MICRONUTRIENT DEFICIENCIES ASSOCIATED WITH RISK OF INTRAPARTUM HEPATITIS E INFECTIONS IN PREGNANT BANGLADESHI WOMEN (2012) (9)
Immunity elicited by hepatitis C virus. (1995) (9)
Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees (2020) (9)
Antigens of hepatitis B virus: failure to detect HBeAg on the surfaces of HBsAg forms. (1978) (9)
A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses. (2015) (9)
Antibody to hepatitis A and B in children in New York City. (1978) (9)
Lack of relationship between Down's syndrome and maternal exposure to Australia antigen. (1972) (8)
Natural History and Experimental Models (2007) (8)
Immunofluorescent localization of hepatitis B antigens in chimpanzee tissues. (1975) (8)
Illness in a chimpanzee inoculated with hepatitis B virus. (1979) (8)
Does non-A, non-B hepatitis cause hepatocellular carcinoma? (1989) (8)
Hepatitis A and Non‐A, Non‐B Viral Hepatitis in São Paulo, Brazil: Epidemiological, Clinical, and Laboratory Comparisons in Hospitalized Patients (2007) (8)
IgM antibody responses to hepatitis B surface antigen in recipients of hepatitis B virus vaccine. (1983) (8)
Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively. (2011) (8)
Genetic relatedness among animal rotaviruses (2005) (8)
Hepatitis and Down's syndrome. (1976) (8)
Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases (1978) (8)
Serologic and animal inoculation studies of a communal outbreak of viral hepatitis, type A (1977) (8)
New methods for the serodiagnosis of hepatitis A. (1980) (8)
Site-directed ELISA identifies a highly antigenic region of the simian immunodeficiency virus transmembrane glycoprotein. (1988) (7)
Evidence for a bidirectional promoter complex within the X gene of woodchuck hepatitis virus. (1998) (7)
International Workshop on Hepatitis B and Liver Cancer: Special Report (1978) (7)
Hepatitis E virus seroprevalence in the United States: No easy answers (2015) (7)
Complete Genome Sequence of a Rat Hepatitis E Virus Strain Isolated in the United States (2014) (7)
Heterogeneity of the woodchuck hepatitis virus genome in a chronically infected woodchuck. (1993) (7)
Recent advances in the identification of hepatitis viruses. (1977) (7)
Influence of alfa interferon on the natural history of chronic hepatitis D:dissociation of histologic and virologic response (2000) (7)
Persistent human hepatitis B virus infection in cynomolgus monkeys: A novel animal model in the search for a cure? (2013) (7)
Rheumatoid factor‐like reactants in sera proven to transmit non‐A, non‐B hepatitis: A potential source of false‐positive reactions in non‐A, non‐B assays (1985) (7)
Frequency and significance of delta antibody in acute and chronic hepatitis B (1985) (7)
IMMUNE RESPONSE TO HEPATITIS VIRUSES (1975) (6)
Current Concepts Hepatitis E (2012) (6)
Hepatitis‐Associated Antigen and Antibody in Cold Ethanol Fractionates of Human Blood (1971) (6)
Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen. (1981) (6)
Pathology of hepatitis delta infection in the Amazon basin. (1987) (6)
Relation between non-A, non-B and delta hepatitis: studies with monoclonal antibodies. (1987) (6)
Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax (2015) (6)
Detection ofHepatitis A Antigen byImmunofluorescence (1977) (6)
Guidelines for the Prevention of Simian Immunodeficiency Virus Infection in Laboratory Workers and Animal Handlers (1989) (5)
The Hepatitis Viruses: An Overview (1994) (5)
Viral Hepatitis Markers in Soviet and American Blood Donors (1980) (5)
Hepatitis B virus DNA detection and comparison with hepatitis B surface antigen (1990) (5)
Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. (1977) (5)
Reproduction In Vitro of a Quasispecies from a Hepatitis C Virus-Infected Patient and Determination of Factors That Influence Selection of a Dominant Species (2011) (5)
Biological and molecular comparisons of human (HM-175) and simian (AGM-27) hepatitis A viruses. (1991) (5)
CLINICAL–LIVER, PANCREAS, AND BILIARY TRACT Long-Term Benefit of Interferon ! Therapy of Chronic Hepatitis D: Regression of Advanced Hepatic Fibrosis (2016) (5)
Isolation of Human Monoclonal Antibodies to the Envelope E2 Protein of Hepatitis C Virus and Their Characterization (2013) (5)
19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage (1990) (4)
Serological markers of hepatitis B virus and hepatitis D virus infections in Greek adults with primary hepatocellular carcinoma (2005) (4)
Current Understanding of Hepatitis B Virus Infection and Its Implications for Immunoprophylaxis (1975) (4)
Viral etiology of the postperfusion syndrome. (1970) (4)
Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans (2020) (4)
The GDPAL region of the pre‐s1 envelope protein is important for morphogenesis of woodchuck hepatitis virus (1998) (4)
Reactivation of chronic hepatitis B as acute viral hepatitis. (1985) (4)
Hepatitis C and its sequelae: the biology of hepatitis C virus and implications for its control. (1995) (4)
The viral hepatitides. (1978) (4)
Expression of the c‐myc protooncogene product in cells infected with the hepatitis delta virus (1994) (4)
Long PCR amplification of large fragments of viral genomes: a technical overview. (2003) (4)
Detection of antibodies to single‐stranded dna in naturally acquired and experimentally induced viral hepatitis (1980) (4)
Hepatitis E virus seroprevalence in the National Health and Nutrition Examination Survey: Facts trump opinion (2015) (4)
Next‐generation sequencing of the intrahepatic antibody repertoire delineates a unique B‐cell response in HBV‐associated acute liver failure (2020) (3)
Viral hepatitis. Light at the end of the tunnel. (1974) (3)
Hepatitis C Virus Envelope Protein E 2 Binds to CD 81 of Tamarins (2000) (3)
Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers. (1978) (3)
Non-A, non-B hepatitis. 1976. (2000) (3)
Mycoplasmas recovered from patients with urethritis. (1973) (3)
Long PCR methodology. (2003) (3)
Hepatitis B vaccines: present status. (1981) (3)
Hepatitis delta infections in Toronto, Ontario (1988) (3)
1048 A NOVEL HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST THE E2 GLYCOPROTEIN OF HEPATITIS C VIRUS (HCV) PREVENTS INFECTION IN CHIMPANZEES (2009) (3)
The relationship between hepatitis B virus infection and hepatic cell carcinoma in Mozambique. (1977) (3)
Demonstration ofSubpopulations ofDaneParticles (1976) (3)
NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection. (1989) (3)
Hepatitis B Core Antigen (1975) (3)
The epidemiology of hepatitis B antigen and antibody among Panamanian Cuna Indians. (1975) (3)
Evidence for non-A, non-B viruses. (1983) (3)
Current status of posttransfusion hepatitis. (1980) (2)
Hepatitis A and Down's syndrome: lack of an association. (1976) (2)
Sequence homology between HDV RNA and 7SL RNA: implications for pathogenesis. (1991) (2)
Experimental transmission of the delta agent to the eastern woodchuck (Marmota monax). (1983) (2)
Reflections on the History of HCV: A Posthumous Examination (2020) (2)
Identification of VP 1 / 2 A and 2 C as Virulence Genes of Hepatitis A Virus and Demonstration of Genetic Instability of 2 C (2002) (2)
Disparate response of monozygotic twins to hepatitis B virus infection. (1977) (2)
Viral hepatitis C, D and E : proceedings of the International Meeting on Non-A, Non-B Hepatitis, Tokyo, 27-30 September 1989 (1991) (2)
New approaches to hepatitis B vaccines. (1983) (2)
Serologic comparison of hepatitis A antigen to echovirus 25 isolate CR69(076) recovered from a patient with viral hepatitis. (1975) (2)
Non-A,Non-BHepatitis (1976) (2)
Titration of recombinant woodchuck hepatitis virus DNA in adult woodchucks (1998) (2)
HEPATITIS C VIRUS (FLAVIVIRIDAE) (1999) (2)
Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV. (1986) (2)
B , and hepatitis C virus genomes . viruses : amplification of hepatitis A , hepatitis Long PCR and its application to hepatitis (1996) (2)
Forum on recent advances in control of infectious diseasesViral hepatitis (1974) (2)
Enterically transmitted non-A, non-B hepatitis. (1990) (1)
Patents and literature (1986) (1)
[Anti-HBc titer in HBeAg(e-antigen) and anti-HBe(anti-e) positive asymptomatic hepatitis B surface antigen (HBsAG) carriers]. (1978) (1)
The hepatitis delta virus and its infection continued. (1987) (1)
Morphologic evolution of frequently fatal delta agent infection in Venezuelan indians. (1983) (1)
Four chimpanzee monoclonal antibodies that neutralize hepatitis A virus (2003) (1)
[Simultaneous inoculation of hepatitis B virus and non-A non-B agents on a chimpanzee: histopathology in relation to electron microscopic and immunologic findings]. (1981) (1)
Enterically Transmitted Hepatitis Viruses: Prospects for Control (1989) (1)
High prevalence of TT virus (TTV) infection in naive chimpanzees and in HCV positive humans. Identification of new TTV genotypes in chimpanzees (2000) (1)
INFECTION AND INFECTION CONTROL (Including Disinfectants) (1975) (1)
Importance of the polymerase chain reaction in the study of hepatitis C virus infection (1993) (1)
Hepatitis A antigen: clinical implications. (1977) (1)
The nature of genetic variation among viruses. (1991) (1)
At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected worldwide ( nonA , non-B hepatitis / genetic heterogeneity / polymerase chain reaction / dendrogram / taxonomy ) (2005) (1)
P.312 Isolation and characterization of hepatitis E virus (HEV)-specific T cell clones from an asymptomatic HEV-exposed subject (2006) (0)
Immunofluorescence ofHepatitis A Virus Antigen inChimpanzees (1978) (0)
Hepatitis research. (1974) (0)
Useful Markers for Predicting in Vivo Infectivity of Hepatitis C Virus (1994) (0)
The Hepatitis delta virus and its infection : proceedings of an international symposium on hepatitis delta virus held in Saint Vincent, Italy, June 19 to 20, 1986 (1987) (0)
43 PACKAGING OF HEPATITIS E VIRUS (HEV) GENOMIC RNA IN TRANS-COMPLEMENTED CAPSID PROTEIN AND PRODUCTION OF INFECTIOUS VIRIONS (2011) (0)
Hepatitis B: a scientific success story (almost). (1985) (0)
Immune Responses In Vitro and In Vivo Oligodeoxynucleotide for Activating Primate Delineation of a CpG Phosphorothioate (2013) (0)
118 GENERATION OF RECOMBINANT HUMAN ANTI-E1 MONOCLONAL ANTIBODIES THAT EFFECTIVELY NEUTRALIZE HCV IN VITRO (2008) (0)
CVI HEV isolation in Egypt (2014) (0)
LXXXV.—The origin of the spectrum of the glow of phosphorus (0)
In vivo transfection by hepatitis A virus synthetic RNA. (1994) (0)
Transmission of the hepatitis B virus-associated 6 agent to the eastern woodchuck ( chronic viral hepatitis / animal model / hepadnavirus ) (0)
Hepatitis Research (1974) (0)
HEV4 O‐22: Human liver chimeric mice as a novel model for the study of hepatitis E virus infections (2015) (0)
Alternative sources of hepatitis B vaccine. (1983) (0)
Hepatitis A Virus Pathogenesis and Attenuation (2002) (0)
T-Cell Response to Hepatitis B and C Virus: Lessons from the Chimpanzee Model (2005) (0)
643 EXPRESSION OF HEPATITIS C VIRUS (HCV) RECEPTORS IN GRAFTS FROM HCV-INFECTED LIVER TRANSPLANT RECIPIENTS (2010) (0)
False-positive serologic test resulting from a probable yeast infection in a chimpanzee (1996) (0)
Hepatitis E. (2007) (0)
Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus (cid:1) (2007) (0)
Thoroughly purified and tre-gaonger klonade hepatite a virus. (1986) (0)
Delta Virus Infection and Severe Hepatitis (2020) (0)
The hepatitis delta virus. Proceedings of the Third International Symposium on Hepatitis Delta Virus. Washington, D.C., October 26-28, 1989. (1990) (0)
Reproduction in vitro of a quasispecies from a hepatitis C patient and determination of factors influencing selection of a dominant species (2011) (0)
Natura1 History of Acute Hepatitis B Surface Antigen-Positive Hepatitis in (1987) (0)
Hepatitis typeA,B,andnon-Anon-Binfulminant hepatitis (1980) (0)
P.430 Comparative pathogenesis of viral hepatitis (2006) (0)
Cloned genome of infectious hepatitis c virus and uses thereof (1998) (0)
THE CHEMICAL NATURE OF ANTIVIRAL SEROTYPE SPECIFICITY (1983) (0)
Foodhandler-Associated Outbreak of Hepatitis Type A (2020) (0)
Worldwide CDMA Forecast and Wireless Trends in the US (1997) (0)
Inaktivering of lipidvirus (1984) (0)
Failure To Detect Polyalbumin-Binding Sites on the Hepatitis Virus Surface Antigen : Implications for the of Hepatitis B Virus in Humans Woodchuck Pathogenesis (0)
Structural Identification of Recombinant HEV VLP C-terminus (2006) (0)
Foerfarande Foer framstaellning of thoroughly purified and tre gaonger klonade the hepatitis A virus. (1986) (0)
Hepatitis A ViruscDNA andItsRNA Transcripts AreInfectious inCellCulture (1987) (0)
DyeMe diated Photolysis of Human Neuroblastoma Cells : Im plications for Autologous Bone Marrow Transplanta tion (2017) (0)
hvr1 Quasispecies Selection And Neutralization By Anti-hvr1 Of Hcv In Cell Culture Are Strongly Influenced By Mutations In The E1e2 Region Outside Of Hvr1 : 1030 (2010) (0)
Viral hepatitis. (1974) (0)
in vivo functional analysis of P7 of hepatitis C virus (2003) (0)
In vivo analysis of the 3' untrans virus after in vitro mutagenesis ( (2016) (0)
Letter: Immune electron microscopy and hepatitis A. (1975) (0)
O.003 Hepatitis E: light at the end of the tunnel? (2006) (0)
Hepatitis Type A and Hemodialysis (2020) (0)
Hauptneutralisationsort of hepatitis E virus and use of this neutralisationsort in vaccination methods and methods for screening for neutralizing antibodies (2000) (0)
Replication and pathology of hepatitis delta virus in tobacco plants (Nicotiana sylvestris): a negative report. (1987) (0)
[Subpopulations and subtypes of Dane particles]. (1978) (0)
Workshop II: Molecular Analysis of Hepatitis B Virus Infection (1988) (0)
LEFT END OF DELETION RESULTS Cloning of WHV DNA from the Serum of a Chronically Infected Woodchuck (2005) (0)
49 – Hepatitis E vaccines (2013) (0)
Failure to transmit human viral hepatitis types A and B to the congenitally athymic nude mouse. (1977) (0)
Procedure for the inactivation of a lipidvirus in the form of hepatitis B virus and / or non-A, non-B hepatitis virus (1984) (0)
Molecular and Biological Approaches to Understanding Hepatitis C Virus (1998) (0)
Effector CD 8 + T cell-derived interleukin-10 enhances acute liver immunopathology Graphical (2017) (0)
The Role of Mycoplasmas in Human Disease (1966) (0)
Molecular analysis of hepatitis B virus infection. (1988) (0)
Persistence of hepatitis C after homolgous monoclonal re-challenge associated with the emergence of new virus variants (2003) (0)
Reply (2017) (0)
Non-A, non-B hepatitis in prison volunteers involved in malarial transmission by blood inoculation (1978) (0)
Mutations Responsible forAdaptation ofHepatitis A Virusto Efficient GrowthinCellCulture (1991) (0)
Hepatitis C virus RNA in southern African Blacks with hepatocellular carcinoma ( nonA , non-B hepatitis / chronic hepatitis / polymerase chain reaction ) (2005) (0)
110 The hepatitis C virus P7 protein, a new target for drug development, is critical for infectivity and contains sequences with genotype-specific function (2003) (0)
Experimental Inoculation of Growing Pigs with U.S. Strains of Swine and Human Hepatitis E Viruses (2000) (0)
Method for inactivating a lipidvirus (1984) (0)
O.029 Analysis of hepatitis E virus mutants in a new cell culture system (2006) (0)
Mutantwoodchuck hepatitis virus genomesfromvirions resemble rearranged hepadnaviral integrants inhepatocellular carcinoma (1993) (0)
Rrekombinante proteins of a Pakistani tribal-of hepatitis e virus, moved their use in diagnotischen and as a vaccine (1998) (0)
Non-A, non-B Hepatitis (1984) (0)
Inactivation d'un virus de lipide (1983) (0)
Cultivation of Mycoplasmas on Glass (1971) (0)
Control of hepatitis A by inactivated vaccines: unanswered questions and unresolved issues. (1993) (0)

This paper list is powered by the following services:

Other Resources About Robert Purcell

en.wikipedia.org

What Schools Are Affiliated With Robert Purcell ?

Robert Purcell is affiliated with the following schools:

Robert Purcell 's Academic­Influence.com Rankings

Why Is Robert Purcell Influential?

Robert Purcell 's Published Works

Published Works

Other Resources About Robert Purcell

What Schools Are Affiliated With Robert Purcell ?

Image Attributions

Robert Purcell 's AcademicInfluence.com Rankings